About EBAMed
EBAMed is a company based in Geneve (Switzerland) founded in 2018. EBAMed has raised $18.64 million across 8 funding rounds from investors including Mayo Clinic, European Union and Liftt. EBAMed offers products and services including External Beam Ablation Devices. EBAMed operates in a competitive market with competitors including AtaCor Medical, AtriCure, Kestra Medical Technologies, CardioFocus and TyRx, among others.
- Headquarter Geneve, Switzerland
-
Sectors
Media & EntertainmentHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ebamed Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.64 M (USD)
in 8 rounds
-
Latest Funding Round
$1.67 M (USD), Series A
Jan 25, 2024
-
Investors
Mayo Clinic
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EBAMed
EBAMed offers a comprehensive portfolio of products and services, including External Beam Ablation Devices.
Tools for non-invasive radio-therapy treatment of heart arrhythmias
People of EBAMed
Unlock access to complete
Software Development Team
3 people
Leadership Team
2 people
Finance and Accounting
1 people
Head Team
1 people
Unlock access to complete
Funding Insights of EBAMed
EBAMed has successfully raised a total of $18.64M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $1.67 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EBAMed
EBAMed has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Mayo Clinic, European Union and Liftt.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and fund of funds focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for EBAMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EBAMed
Investment portfolio details for EBAMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EBAMed
Detailed financials for EBAMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ebamed Comparisons
Peer comparison for EBAMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EBAMed
EBAMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, Kestra Medical Technologies, CardioFocus and TyRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Antibacterial envelopes are developed for stabilizing cardiac implantable devices.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
Detailed competitors of EBAMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ebamed
Complete news archive for EBAMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EBAMed
EBAMed was founded in 2018 and raised its 1st funding round 1 year after it was founded.
EBAMed is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
EBAMed is a funded company, having raised a total of $18.64M across 8 funding rounds to date.
EBAMed was founded in 2018 in Geneva, Switzerland, as a medical device company in the healthcare sector. Innovative solutions for non-invasive and automated treatment of heart arrhythmias are developed, incorporating technologies such as proton therapy. Efficient options for patients are targeted through these products. Significant funding has been secured to support technology advancement and product expansion. Operations focus on improving treatment outcomes in cardiac care.
EBAMed's top competitors include AtaCor Medical, AtriCure and CardioFocus.
EBAMed offers External Beam Ablation Devices.
EBAMed has 9 investors. Key investors include Mayo Clinic, European Union, Liftt, CDP Venture Capital, and Panakes Partners.